Strand V - Search Results

1

Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop.

Morgan EM, Munro JE, Horonjeff J, Horgan B, Shea B, Feldman BM, Clairman H, Bingham CO 3rd, Thornhill S, Strand V, Alongi A, Magni-Manzoni S, van Rossum MAJ, Vesely R, Vojinovic J, Brunner HI, Harris JG, Horton DB, Lovell DJ, Mannion M, Rahimi H, Ravelli A, Ringold S, Ruperto N, Schrandt MS, Shenoi S, Shiff NJ, Toupin-April K, Tzaribachev N, Weiss P, Consolaro A. Morgan EM, et al. Among authors: strand v. J Rheumatol. 2019 Aug;46(8):1006-1013. doi: 10.3899/jrheum.181088. Epub 2019 Feb 15. J Rheumatol. 2019. PMID: 30770499

2

OMERACT II: the biologics perspective.

Strand V. Strand V. J Rheumatol. 1995 Jul;22(7):1415-7. J Rheumatol. 1995. PMID: 7562788 Review.

3

Health status instruments / utilities.

Bellamy N, Boers M, Felson D, Fries J, Furst D, Henry D, Liang M, Lovell D, March L, Strand V, et al. Bellamy N, et al. Among authors: strand v. J Rheumatol. 1995 Jun;22(6):1203-7. J Rheumatol. 1995. PMID: 7674258

4

Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III.

Bellamy N, Kirwan J, Boers M, Brooks P, Strand V, Tugwell P, Altman R, Brandt K, Dougados M, Lequesne M. Bellamy N, et al. Among authors: strand v. J Rheumatol. 1997 Apr;24(4):799-802. J Rheumatol. 1997. PMID: 9101522 Review.

5

Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress report for the OMERACT Drug Toxicity Working Party. Outcome Measures in Rheumatology.

Gazarian M, Tugwell P, Boers M, Bombardier C, Brooks P, Day R, Strand V, Wells G. Gazarian M, et al. Among authors: strand v. J Rheumatol. 1999 Jan;26(1):207-9. J Rheumatol. 1999. PMID: 9918265

6

Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference.

Beaton DE, Bombardier C, Katz JN, Wright JG, Wells G, Boers M, Strand V, Shea B. Beaton DE, et al. Among authors: strand v. J Rheumatol. 2001 Feb;28(2):400-5. J Rheumatol. 2001. PMID: 11246687 Review.

7

Minimal clinically important differences: review of methods.

Wells G, Beaton D, Shea B, Boers M, Simon L, Strand V, Brooks P, Tugwell P. Wells G, et al. Among authors: strand v. J Rheumatol. 2001 Feb;28(2):406-12. J Rheumatol. 2001. PMID: 11246688 Review.

8

Patient based method of assessing adverse events in clinical trials in rheumatology: the revised Stanford Toxicity Index.

Welch V, Singh G, Strand V, Fries J, Boers M, Ramey D, Day RO, Brooks P, Tugwell P, Clinch J, Kristjansson B. Welch V, et al. Among authors: strand v. J Rheumatol. 2001 May;28(5):1188-91. J Rheumatol. 2001. PMID: 11361211 Review.

9

Leflunomide for treating rheumatoid arthritis.

Osiri M, Shea B, Robinson V, Suarez-Almazor M, Strand V, Tugwell P, Wells G. Osiri M, et al. Among authors: strand v. Cochrane Database Syst Rev. 2003;2002(1):CD002047. doi: 10.1002/14651858.CD002047. Cochrane Database Syst Rev. 2003. PMID: 12535423 Free PMC article. Review.

10

OMERACT workshop: repair of structural damage in rheumatoid arthritis.

Van Der Heijde D, Sharp JT, Rau R, Strand V; Subcommittee on Healing of Erosions of the OMERACT Imaging Committee. Van Der Heijde D, et al. Among authors: strand v. J Rheumatol. 2003 May;30(5):1108-9. J Rheumatol. 2003. PMID: 12734917 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

534 results

Search Page

Filters